Ars Technica • 11/4/2026

The DEA has banned a drug that some opioid users referred to as a miracle. Researchers indicate that this Schedule I ban could hinder studies of a promising opioid treatment.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.








